Willow Biosciences Inc. (WLLW.TO)
$0.17
+0.01 (+6.25%)
Rating:
Recommendation:
-
| Symbol | WLLW.TO |
|---|---|
| Price | $0.17 |
| Beta | 1.116 |
| Volume Avg. | 0.17M |
| Market Cap | 21.012M |
| Shares () | - |
| 52 Week Range | 0.155-1.15 |
| 1y Target Est | - |
| DCF Unlevered | WLLW.TO DCF -> | |
|---|---|---|
| DCF Levered | WLLW.TO LDCF -> | |
| ROE | 7.24% | Neutral |
| ROA | 7.24% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 11.48% | Neutral |
| P/E | 5.67 | Buy |
| P/B | 0.77 | Buy |
About
Download (Excel)Mr. Trevor Anthony Peters
Healthcare
Drug Manufacturers—Specialty & Generic
Toronto Stock Exchange
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.